PARP inhibitors in advanced prostate cancer

Advanced #ProstateCancer Treatments & Side Effects In 2024 | Elisabeth Heath, MD #PCRI #2024PCRIConfПодробнее

Advanced Prostate Cancer: Why is CGP important? A Pioneers in Practice WebinarПодробнее

PARP Inhibitors: Assessing the Rapidly Evolving Treatment LandscapeПодробнее

PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The CommunityПодробнее

PARP Inhibitors: Assessing the Clinical Trial LandscapeПодробнее

An Overview of PARPi & Adverse Event ManagementПодробнее

Foundation Frontiers Webinar - Liquid Biopsy in Advanced Prostate Cancer: Stay Up To DateПодробнее

AUA2024: The Changing Face of Advanced Prostate CancerПодробнее

PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to TestПодробнее

Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into PracticeПодробнее

Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side EffectsПодробнее

PARPi: Precision Medicine in Advanced Prostate CancerПодробнее

AUA2023: AUA Guidelines on Advanced Prostate CancerПодробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

PARP Inhibitors in Advanced Prostate Cancer CareПодробнее

Systemic Therapies for mHSPC and Castrate Resistant Prostate CancerПодробнее

Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP InhibitorsПодробнее

The Evolving Treatment Landscape of Advanced Prostate CancerПодробнее

Systemic Therapy Approaches for Advanced Prostate CancerПодробнее

"Integration of Novel Targeted Therapies and the Treatment of Advanced Prostate Cancer"Подробнее